The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production
Abstract
Summary: We hypothesized that the aberrant expression of microRNAs (miRNAs) in rheumatoid arthritis (RA) T cells was involved in the pathogenesis of RA. The expression profile of 270 human miRNAs in T cells from the first five RA patients and five controls were analysed by real-time polymerase chain reaction. Twelve miRNAs exhibited potentially aberrant expression in RA T cells compared to normal T cells. After validation with another 22 RA patients and 19 controls, miR-223 and miR-34b were over-expressed in RA T cells. The expression levels of miR-223 were correlated positively with the titre of rheumatoid factor (RF) in RA patients. Transfection of Jurkat cells with miR-223 mimic suppressed insulin-like growth factor-1 receptor (IGF-1R) and transfection with miR-34b mimic suppressed cAMP response element binding protein (CREB) protein expression by Western blotting. The protein expression of IGF-1R but not CREB was decreased in RA T cells. The addition of recombinant IGF-1-stimulated interleukin (IL)-10 production by activated normal T cells, but not RA T cells. The transfection of miR-223 mimic impaired IGF-1-mediated IL-10 production in activated normal T cells. The expression levels of SCD5, targeted by miR-34b, were decreased in RA T cells after microarray analysis. In conclusion, both miR-223 and miR-34b were over-expressed in RA T cells, but only the miR-223 expression levels were correlated positively with RF titre in RA patients. Functionally, the increased miR-223 expression could impair the IGF-1-mediated IL-10 production in activated RA T cells in vivo, which might contribute to the imbalance between proinflammatory and anti-inflammatory cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR-223 is differentially expressed between the PBMCs and plasma in RA patients, suggesting that miR-223 could be a biological marker for RA diagnosis 95-98.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236
Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., & Kumagai, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24475 · Cited by 332
O’Connor, J. C., McCusker, R. H., Strle, K., Johnson, R. W., Dantzer, R., & Kelley, K. W. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.010 · Cited by 238
Research works printed but not linked: 47
- Cooles, 2011, Pathophysiology of rheumatoid arthritis, Curr Opin Rheumatol, 23, 233, 10.1097/BOR.0b013e32834518a3 · DOI · Paper page
- Isaacs, 2008, Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future, Rheumatology (Oxf), 47, 1461, 10.1093/rheumatology/ken163 · DOI
- Goronzy, 2009, Developments in the scientific understanding of rheumatoid arthritis, Arthritis Res Ther, 11, 249, 10.1186/ar2758 · DOI
- Pratt, 2012, A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease, Ann Rheum Dis, 71, 1374, 10.1136/annrheumdis-2011-200968 · DOI
- Kremer, 2003, Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med, 349, 1907, 10.1056/NEJMoa035075 · DOI · Paper page
- Pauley, 2009, MicroRNA in autoimmunity and autoimmune diseases, J Autoimmun, 32, 189, 10.1016/j.jaut.2009.02.012 · DOI · Paper page
- Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc Natl Acad Sci USA, 108, 11193, 10.1073/pnas.1019536108 · DOI · Paper page
- Semaan, 2011, miR-346 controls release of TNF-alpha protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization, PLOS ONE, 6, e19827, 10.1371/journal.pone.0019827 · DOI
- Pauley, 2008, Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res Ther, 10, R101, 10.1186/ar2493 · DOI · Paper page
- Zhu, 2012, The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha, Nat Med, 18, 1077, 10.1038/nm.2815 · DOI · Paper page
- Stanczyk, 2011, Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation, Arthritis Rheum, 63, 373, 10.1002/art.30115 · DOI · Paper page
- Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum, 58, 1284, 10.1002/art.23429 · DOI · Paper page
- Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum, 58, 1001, 10.1002/art.23386 · DOI · Paper page
- Fulci, 2010, miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis, Hum Immunol, 71, 206, 10.1016/j.humimm.2009.11.008 · DOI · Paper page
- Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 · DOI · Paper page
- Chen, 2005, Real-time quantification of microRNAs by stem-loop RT–PCR, Nucleic Acids Res, 33, e179, 10.1093/nar/gni178 · DOI · Paper page
- Lai, 2013, Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis, Clin Exp Immunol, 173, 47, 10.1111/cei.12089 · DOI
- Lu, 2013, Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis, Clin Exp Immunol, 171, 91, 10.1111/j.1365-2249.2012.04676.x · DOI
- Jordan, 2008, Optimizing electroporation conditions in primary and other difficult-to-transfect cells, J Biomol Tech, 19, 328
- Jia, 2011, MiR-223 suppresses cell proliferation by targeting IGF-1R, PLOS ONE, 6, e27008, 10.1371/journal.pone.0027008 · DOI
- Pigazzi, 2009, miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia, Cancer Res, 69, 2471, 10.1158/0008-5472.CAN-08-3404 · DOI
- Kooijman, 2004, Insulin-like growth factor-I stimulates IL-10 production in human T cells, J Leukoc Biol, 76, 862, 10.1189/jlb.0404248 · DOI
- Li, 2010, Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis, Arthritis Res Ther, 12, R81, 10.1186/ar3006 · DOI · Paper page
- Niimoto, 2010, MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients, BMC Musculoskelet Disord, 11, 209, 10.1186/1471-2474-11-209 · DOI · Paper page
- Sebastiani, 2011, Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients, Clin Exp Rheumatol, 29, 1058
- Filková, 2013, Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis, Ann Rheum Dis, 10.1136/annrheumdis-2012-202815 · DOI · Paper page
- Murata, 2010, Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis, Arthritis Res Ther, 12, R86, 10.1186/ar3013 · DOI · Paper page
- Pandis, 2012, Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model, Ann Rheum Dis, 71, 1716, 10.1136/annrheumdis-2011-200803 · DOI
- Shibuya, 2013, Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation, Mod Rheumatol, 23, 674, 10.3109/s10165-012-0710-1 · doi:10.3109/s10165-012-0710-1
- Sugatani, 2007, MicroRNA-223 is a key factor in osteoclast differentiation, J Cell Biochem, 101, 996, 10.1002/jcb.21335 · DOI · Paper page
- Li, 2012, Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223, Arthritis Rheum, 64, 3240, 10.1002/art.34550 · DOI
- Engvall, 2008, Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor, Scand J Rheumatol, 37, 321, 10.1080/03009740802055984 · DOI
- Lemmey, 2001, Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis, J Rheumatol, 28, 29
- Neidel, 2001, Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis, Clin Exp Rheumatol, 19, 81
- Dhaunsi, 2012, Insulin-like growth factor-1 gene polymorphism in rheumatoid arthritis patients, Scand J Rheumatol, 41, 421, 10.3109/03009742.2012.691177 · DOI
- Laurberg, 2012, Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naive rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment, Rheumatol Int, 32, 501, 10.1007/s00296-010-1683-z · DOI
- Boström, 2011, Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis, Arthritis Rheum, 63, 2894, 10.1002/art.30527 · DOI
- Friedrich, 2008, Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP), Growth Horm IGF Res, 18, 228, 10.1016/j.ghir.2007.09.005 · DOI
- Katsikis, 1994, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med, 179, 1517, 10.1084/jem.179.5.1517 · DOI · Paper page
- O'Shea, 2002, Cytokines and autoimmunity, Nat Rev Immunol, 2, 37, 10.1038/nri702 · DOI · Paper page
- Joosten, 1997, Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction, Arthritis Rheum, 40, 249, 10.1002/art.1780400209 · DOI · Paper page
- Heo, 2010, IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients, Immunol Lett, 127, 150, 10.1016/j.imlet.2009.10.006 · DOI
- Schenten, 2014, Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells, Immunity, 40, 78, 10.1016/j.immuni.2013.10.023 · DOI
- Croft, 2014, The TNF family in T cell differentiation and function – unanswered questions and future directions, Semin Immunol, 10.1016/j.smim.2014.02.005 · DOI
- Wakisaka, 1998, Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis, Ann Rheum Dis, 57, 487, 10.1136/ard.57.8.487 · doi:10.1136/ard.57.8.487
- Kotla, 2013, The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis, Sci Signal, 6, ra83, 10.1126/scisignal.2004214 · DOI
- Sinner, 2012, StearoylCoA desaturase-5: a novel regulator of neuronal cell proliferation and differentiation, PLOS ONE, 7, e39787, 10.1371/journal.pone.0039787 · DOI
Cited by
Chen, Z., Wang, H., Xia, Y., Yan, F., & Lu, Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800304 · Cited by 329
MicroRNAs: Roles in Regulating Neuroinflammation
Gaudet, A. D., Fonken, L. K., Watkins, L. R., Nelson, R. J., & Popovich, P. G. (2018) · The Neuroscientist · doi:10.1177/1073858417721150 · Cited by 236
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
Insulin Signaling in Arthritis
Tripolino, C., Ciaffi, J., Pucino, V., Ruscitti, P., van Leeuwen, N., Borghi, C., Giacomelli, R., Meliconi, R., & Ursini, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672519 · Cited by 46
Metadata
- Authors
- Lu, M.-C., Yu, C.-L., Chen, H.-C., Yu, H.-C., Huang, H.-B., & Lai, N.-S.
- Affiliations
- Division of Allergy, Immunology, and Rheumatology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
- Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
- Department of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan
- Department of Life Science and Institute of Molecular Biology, National Chung Cheng University, Chiayi, Taiwan
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-07-24
- Volume
- 177
- Issue
- 3
- Pages
- 641-651
- ISSN
- 0009-9104
- 1365-2249
- Cited by
- 83
- References
- 5
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- National Science Council (101-2314-B-303-028-MY3)
- Dalin Tzu Chi Hospital (DTCRD101-I-07)
- Buddhist Tzu Chi Medical Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.